Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Colorectal cancer incidence and mortality have increased among younger adults in recent years, with the most significant increase seen in those ages 40 to 49. Starting FIT screening early was tied to ...

A new analysis provided “strong” support for starting fecal immunochemical test (FIT) screening at ages 40-49 rather than at the currently recommended age of 50. An exploratory initiative that offered ...

Screening for colorectal cancer could become much cheaper and less invasive.

A new report found that colorectal cancer causes more deaths than any other type of cancer, including breast and lung cancers ...

Historically, the gold standard for diagnosing colorectal cancer has been a colonoscopy. During the procedure, a thin tube with a camera is inserted into the rectum, which lets the doctor examine the ...

Findings compared with three opt-in screening strategies among average-risk adults aged 45 to 49 years. HealthDay News — Mailing a stool-based test directly to people’s homes is the most effective ...

Every year, doctors diagnose more than 107,000 cases of colorectal cancer. While survival rates have improved, it's still the second-leading cause of cancer deaths in men and women combined. Knowing ...